Regarding treatment at the time of diagnosis of CMV infection, nine (20.0%) patients were on monotherapy with advanced treatment [five with anti-Tumor Necrosis Factor (anti-TNF) (11.1%), three with vedolizumab (6.7%) and one with tofacitinib (2.2%)], one with azathioprine and eight (17.8%) with corticosteroids. Here, TNF is linked to cytomegalovirus infection.